- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 10, 2025 | 837.96K sh |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $2.26M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $1.05M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $2.26M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $2.62M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $1.21M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $815.7K |
| Total Assets | Q2 2025 · Mar 31, 2025 | $2.68M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $2.51M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 600.18K sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 600.18K sh |
| Operating Cash Flow restated | Q2 2025 · Mar 31, 2024 | −$108.15K |
| Stockholders Equity restated | Q2 2025 · Mar 31, 2024 | $805.8K |
| Stockholders Equity restated | Q2 2025 · Dec 31, 2023 | $786.24K |
| Stockholders Equity restated | Q2 2025 · Sep 30, 2023 | $790.45K |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.03 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.03 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $20.13K |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $55.33K |
| Net Income restated | Q2 2025 · Mar 31, 2024 | $19.56K |
| Net Income restated | Q2 2025 · Mar 31, 2024 | $15.36K |
| Operating Income | Q2 2025 · Mar 31, 2024 | $42.15K |
| Operating Income | Q2 2025 · Mar 31, 2024 | $52.62K |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $383.44K |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $676.92K |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $496.39K |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $1.03M |